microdosing glp 1 menopause THE PCCA BLOG Ashley Koff on GLP-1s and

Combination treatments working at different receptors promise weight loss with fewer side effects

The platform cannot guarantee that any individual will receive a prescription that determination rests entirely with the evaluating clinician

P., Albiero, M., Menegazzo, L., de Kreutzenberg, S

1 How it works The design of orforglipron emphasizes stability in the GI tract, which allows oral dosing while preserving target engagement

It may hold promise for certain women navigating menopause-related weight challenges, but its not a DIY solution, and it absolutely requires the guidance of a provider who understands both the science and the unique needs of midlife women